Based on its deep expertise in mRNA vaccine development and in-house manufacturing capabilities ... Genmab, MediLink, OncoC4, Pfizer and Regeneron. For more information, please visit www.BioNTech.com.

The acquisition was part of BioNTech's broader oncology strategy, backed by the financial success of its Covid-19 vaccine ...

Most people don't enjoy getting shots for treatments or vaccines. So, researchers are working to create more medicines, such ...